On Apr. 6, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. BioReference provides real-time reverse-transcription polymerase chain reaction assay with expected 24-72 hour turnaround time.